• Title/Summary/Keyword: Atopic Dermatitis(AD)

Search Result 315, Processing Time 0.023 seconds

A Study of Atopic Dermatitis Treated with Ceramic Based Infra-red Therapy (아토피성 피부염의 광선치료(GI-2000) 효과)

  • Shim, Sang-Min;Jung, Ae-Suk
    • The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
    • /
    • v.17 no.3
    • /
    • pp.80-87
    • /
    • 2004
  • Objectives : Ceramic based intra-red Therapy has been effective on dermatitis and immune system. The purpose of this study was to know the clinical effect of ceramic based infra-red therapy on Atopic Dermatitis(AD). Methods: For 3 months from Dec. 2003 to Feb. 2004, we treated ceramic based intra-red therapy to 21 outpatients with AD who visited Hana Oriental hospital. Ceramic based infra-red therapy using GI-2000 system was lighted to undressed outpatients for 15 minutes, three times a week. Results and Conclusions: Ceramic based intra-red therapy showed useful effect on AD, especially itching sign.

  • PDF

The Use of Oriental Medicine for Pediatric Outpatients with Atopic Dermatitis (한방병원 소아과를 내원한 소아 아토피피부염 환자 실태에 관한 조사)

  • Jo, Min-Seo;Han, Jae-Kyung;Kim, Yun-Hee
    • The Journal of Pediatrics of Korean Medicine
    • /
    • v.25 no.2
    • /
    • pp.8-14
    • /
    • 2011
  • Objectives: This study is performed to investigate the use of oriental medicine on pediatric outpatients with atopic dermatitis(AD). Methods: The study was carried out with 267 AD outpatients who visited the Department of Pediatrics, Oriental Medical Hospital from January 2010 to May 2011 and was completed by reviewing patients' chart. Results: The relative frequency of AD on the oriental pediatrics hospital was 6.8%. In a sexual distribution, the male children were more frequent than the females. In an age distribution, atopic dermatitis children visited the hospital were the most frequent in the age from 3 to 10. The highest frequency that started the oriental therapy after the outbreak of AD was from 1 month to 1 year. Approximately, 49.4% of the children who visited hospital relied on western medicine in treating their atopic dermatitis. The therapeutic effect of the oriental medicine was found to be excellent in 47.9%, no change was seen in 16.9%, and aggravation was seen in 3.4% of the patients. Less than a month of oriental treatment was the most common. The improvement depending on the length of the treatment was found to be 91.8% in more than 3 months, and 21.8% in less than 1 month. The use of the herbal medicine and herbal external treatment was seen in 67.4% and the therapeutic effect was improved in 63.3% of the patients. Conclusions: Considering the results, we can improve accommodation of oriental therapies for the pediatric outpatients with atopic dermatitis, and enhance the doctor-patient relationship to help the children with atopic dermatitis.

Evaluation of the Atopic Dermatitis-mitigating and Anti-inflammatory Effects of Kyung Hee Allergic Disease Herbal Formula (KAHF)

  • Koh, Duck-Jae;Kim, Yang-Hee;Kim, Deog-Gon;Lee, Jin-Yong;Lee, Kyung-Tae
    • Food Science and Biotechnology
    • /
    • v.17 no.6
    • /
    • pp.1272-1278
    • /
    • 2008
  • The purpose of this study was to investigate the effects of Kyung Hee Allergic Disease Herbal Formula (KAHF) on atopic dermatitis (AD) and its mode of action. Our clinical study showed KAHF reduced Severity Scoring of Atopic Dermatitis (SCORAD) indexes and subjective symptom scores. In parallel, the decreased levels of interferon (IFN)-$\gamma$ and interleukin (IL)-5 in serum, which contributed to its AD-mitigating effect was observed. To reveal the underlying mechanisms of KAHF in AD, its anti-inflammatory effect on lipopolysaccharide (LPS)-induced responses in RAW 264.7 cells was examined. KAHF was found to significantly inhibit the productions of nitric oxide (NO), prostaglandin $E_2$ ($PGE_2$), and IL-$1{\beta}$ in LPS-stimulated RAW 264.7 macrophages. Consistently, KAHF potently inhibited protein and mRNA expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Furthermore, KAHF inhibited LPS-induced activation of nuclear factor (NF)-$\kappa}B$. Taken together, our data suggest that KAHF has a beneficial effect on several eicosanoid-related skin inflammations, such as atopic dermatitis.

Relationships among Behavior Problem, Peer Interaction, and Parental Factors in Young Boys and Girls with Atopic Dermatitis (유아의 성별 문제행동과 또래상호작용 및 부모 요인과의 관계: 아토피피부염 유아를 중심으로)

  • Chun, Hui Young
    • Korean Journal of Childcare and Education
    • /
    • v.12 no.6
    • /
    • pp.19-39
    • /
    • 2016
  • The present study examined differences in children's behavior problems and peer interaction, and parental factors including self-esteem, depression and childrearing stress between atopic dermatitis(AD) and normal(non-AD) children in each gender, and analyzed the effects of the parental factors on the two variables of AD children. 165 AD and 1176 non-AD children of age 5 were selected from the 6th year data of the Panel Study on Korean Children. The results from t-test and multiple regression are as follows. First, only AD boys showed a higher level of behavior problems than non-AD boys, but peer interaction showed no difference between AD and non-AD groups. Compared with non-AD children's parents, mothers of AD children showed a higher stress level and mothers of AD boys had a higher depression level. But there were no differences in maternal self-esteem and paternal factors between the groups. Second, AD boys' behavior problems were related to maternal factors and paternal stress, and some characteristics of AD girls' behavior problems were related with some parental variables. But peer interaction of AD children had no relation with parental factors. Third, behavior problems were influenced by maternal stress in AD boys and influenced by maternal depression and parental self-esteem in AD girls.

Recovery Effect of Blending Oil on Skin Barrier Damaged by Atopic Dermatitis (아토피피부염의 손상된 피부장벽에 대한 혼합오일의 회복 효과)

  • Seo, Young Mi
    • Journal of East-West Nursing Research
    • /
    • v.20 no.1
    • /
    • pp.57-62
    • /
    • 2014
  • Purpose: The purpose of this study was to evaluate the effect of a mixture of ARL oils, Agastache rugosa, Rosemarinu officinalis, and Lavandula angustifolia on atopic dermatitis (AD) model on NC/Nga mice. Methods: Twenty-four, 6 week-NC/Nga mice were assigned to a control group (C, n=8), an AD-induced group (E, n=8), and an ARL oil-treated group (E, n=8) that had two treatments per day for 6 days. Epidermis thickness, total amount of collagen and expression of TGF-${\beta}$ in the AD induced mice were measured. Results: The ARL oil-treated group showed a significantly decreased epidermis thickness, and a greater amount of collagen and expression of TGF-${\beta}$ compared with the AD-induced group. Conclusison: ARL oil may be a putative resources for care or treatment of AD in the view of nursing intervention.

The regulatory effect of AST cream on atopic dermatitis-like skin disease.

  • Han, Na-Ra;Kim, Hyung-Min;Jeong, Hyun-Ja
    • CELLMED
    • /
    • v.9 no.3
    • /
    • pp.7.1-7.4
    • /
    • 2019
  • In this study, we investigated an inhibitory effect of AST cream on atopic dermatitis (AD) using a 2,4-dinitrochlorobenzene-induced AD murine model. Topical treatment with AST cream ameliorated the severity of AD-like lesional skin through decreases in infiltration of inflammatory cells and time of scratching behaviors. Also, AST cream reduced histamine and IgE levels in serum. The protein levels of IL-4 and IL-6 in AD-like lesional skin were suppressed by AST cream. These findings suggest that AST cream would be an alternative therapeutic agent for AD-like skin diseases.

Development of Atopic Dermatitis Mouse Model with Spleen Deficiency (비허형 아토피 동물모델 개발)

  • Yang, Won Kyung;Lyu, Yee Ran;Kim, Ho Kyoung;Kim, Seung Hyeong;Park, Yang Chun
    • Journal of Physiology & Pathology in Korean Medicine
    • /
    • v.31 no.4
    • /
    • pp.213-219
    • /
    • 2017
  • Atopic dermatitis (AD) is a common skin disease characterized by chronic and relapsing inflammatory dermatitis with immunological disturbances. Spleen deficiency (脾虛) is one of the major causes of AD, so development of animal model is required for AD research that reflects the pattern identification. The groups that we have used in this study included Senna folium extracts (SFE), 2,4-dinitrochlorobenzene (DNCB), and normal mice. Therefore, the present study was developed to atopic dermatitis mouse model with spleen deficiency in 2,4-dinitrochlorobenzene (DNCB) and senna leaves extracts induced AD in NC/Nga mice. The results demonstrated that senna leaves extract treatment significantly increased the dermatitis clinical score and epidermal thickness in AD-like skin lesions. We also proved beyond doubt that there was occurrence of erythema and skin moisture indices in the senna leaves extract groups. Further, we also found that the level of serum immunoglobulin E (IgE) in the senna leaves extract-treated group was increased. The amount of IL-4, IL-13, $TNF-{\alpha}$ and $TGF-{\beta}$ mRNA determined by real-time PCR was increased remarkably when senna leaves extract groups were treated on dorsal skin. Senna leaves extract groups significantly promoted the number of CD11B+/Gr-1 cell in skin, as well as the number of CD4+/CD8+ cell in dorsal skin compared with control. The review summarizes recent process in our understanding of the immunopathophysiology of spleen deficiency AD and the implications for spleen deficiency mouse models of AD on drug discovery from medical plants.

Analysis of Prevalence of Anemia according to Severity of Atopic Dermatitis (아토피 피부염 심각도에 따른 빈혈 유병률 비교 분석)

  • Yun, Dai;Chang, Ji-Eun;Rhew, Kiyon
    • Korean Journal of Clinical Pharmacy
    • /
    • v.30 no.4
    • /
    • pp.264-269
    • /
    • 2020
  • Background: Inflammatory diseases can increase the prevalence of anemia. Recent studies confirmed that the prevalence of anemia is increased by atopic dermatitis (AD), a chronic inflammatory disease. Therefore, we aimed to elucidate the correlation between AD severity and prevalence of anemia. Methods: We used data of pediatric patients from the Health Insurance Review and Assessment Service (HIRA-PPS-2016). We included pediatric patients (<18 years) with AD diagnosis who were prescribed medications for AD. We applied a propensity score method with inverse probability of treatment weighting (IPTW) adjusting for differences in prevalence of confounders and performed IPTW logistic regression to evaluate associations between the anemia and severity of AD. Results: In total, 91,501 patients (mild AD: 47,054 patients; moderate-to-severe AD: 44,447 patients) <18 years who were prescribed drugs for AD were analyzed. Analysis of the probability of patients with mild AD and prevalence of anemia as a reference revealed an odds ratio (OR) of 1.159 (95% CI, 1.109-1.212; p<0.001) in moderate-to-severe AD patients, indicating a correlation between anemia prevalence and AD severity. Subgroup analysis according to gender, age group, and type of health insurance revealed there was an association between AD severity and anemia except in patients equal or older than 7 years. Conclusion: The prevalence of anemia increased with AD severity despite adjusting for confounding factors. Our results support the hypothesis that AD can cause anemia, and anemia prevalence could be increased in severe AD patients. Further studies are needed to establish a pathological basis.

A Noble Therapeutic Approach of Atopic dermatitis by Development of Th2 Chemokine Inhibitors from Natural Products : Inhibitory Effect of Sophora flavescens Extract in Atopic Dermatitis Model mice, NC/Nga (천연물 유래 Th2 케모카인 억제제 발굴에 의한 새로운 아토피 피부염 치료기술 개발 : 아토피 피부염 모델 NC/Nga 마우스에서 고삼 추출액의 억제 효과)

  • Jeong, Seung-Il;Choi, Byung-Min;Yun, Young-Gab;Lee, Jang-Won;Jang, Seon-Il
    • Herbal Formula Science
    • /
    • v.17 no.1
    • /
    • pp.141-151
    • /
    • 2009
  • We investigated the inhibitory effect of an oral administration of a Sophora flavescens Aiton ethanol extract (SFE) on the development of atopic dermatitis (AD) by using NC/Nga model mice. The induction of atopic dermatitis-like lesion was conducted by the removal of the back hairs and topical application of a mite antigen (Dermatophagoides farinae, Df) on to the back skin twice a week for 8 weeks. SFE was orally administered at a different doses (100-400 mg/kg). Atopic dermatitis-like skin lesions were evaluated by dermatitis scores, skin histology and immunological parameters (serum levels of IgE, TARC/CCL17, MDC/CCL22, and CTACK/CCL27). Oral administration of SFE significantly inhibited the clinical sign of Df-induced atopic dermatitis, including dermatitis score and leukocyte infiltration. Moreover, SFE suppressed significantly the serum IgE and Th2 chemokine (TARC/CCL17, MDC/CCL22, and CTACK/CCL27) levels in a concentration dependent manner. These results suggest that oral administration of SFE could reduce significantly the clinical signs and Th2 chemokines in Df-induced atopic dermatitis model mice. Therefore, SFE may be effective substances for the management of AD in human.

  • PDF

The Effects of Bangpungtongsungsan Extract to the Skin Damage on Mice Model after Atopic Dermatitis Elicitation (방풍통성산(防風通聖散)이 아토피 피부염을 유발한 동물모델의 피부 손상에 미치는 영향)

  • Son, Jung-Min;Hong, Seung-Ug
    • The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
    • /
    • v.20 no.1 s.32
    • /
    • pp.99-114
    • /
    • 2007
  • Objectives : Atopic dermatitis has a close relationship with damage of skin barrier function. To investigate the effects of Bangpungtongsungsan(BT) extract to the skin damage on mice model after atopic dermatitis elicitation, this study was done through forcing injury to mice's skin. Methods : The BALB/c mice were distributed into three groups: control(CON) group, atopic dermatitis(AD)-elicited group, Bangpungtongsungsan(BT)-treated group. AD-elicited and BT-treated group were caused AD according to the method of Christophers E., Mrowietz and Minehiro. The BT extract was administered for 48 hours to BT-treated group. We observed changes of external dermal formation, eosinophils in vasculature, lipid formation in stratum corneum, distribution of ceramide, distribution of capillary, $I{\kappa}B$ kinase(IKK) and induce nitric oxide synthase(iNOS) mRNA expression. We used the statistical methods of student t-test(p<0.05). Results : After dispensing BT extract into the AD-elicited group, the number of eosinophil as an atopic index in mice noticeably decreased and dermal injury decreased. Also the decrease of hyperplasia, degranulated mast cells, angiogenesis and substance P were shown. The lipid lamellae, lipid protect formation, were repaired and the distribution of ceramide which inhibit protein kinase C(PKC) activation increased, and the PKC caused inhibition of nuclear $factor(NF)-{\kappa}B$ activation. As a result of inhibition of $NF-{\kappa}B$ activation, iNOS production were inhibited and apoptotic cell were increased. Moreover the decrease of IKK and iNOS mRNA expression in BT-treated RAW 264.7 cell were noted. Conclusion : BT mitigated skin damage on mice model after atopic dermatitis elicitation through recovering skin barrier function and inhibiting nuclear $factor(NF)-{\kappa}B$ activation.

  • PDF